Nevro could grab a fifth of US spinal cord stim market by 2019
This article was originally published in Clinica
Executive Summary
Dominant players in the spinal cord stimulation market should start looking over their shoulder, as relative new kid on the block Nevro is predicted to capture around 20% of the US market four years from now.